MedPath

AURO-ONDANSETRON ODT

AURO-ONDANSETRON ODT

Approved
DIN Number

02511282

Drug Class

Human

Market Date

Dec 23, 2021

Company
HC

auro pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02511282
AIG Number0131120003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A04AA01 ONDANSETRON
Product Specifications
Dosage FormTablet (Orally Disintegrating)
Route of AdministrationOral
AHFS Classification56:22.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

ONDANSETRONActive
Strength: 4 MG
Monograph: ONDANSETRON

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.